Last reviewed · How we verify
Reference001 - Hydrocodone
At a glance
| Generic name | Reference001 - Hydrocodone |
|---|---|
| Sponsor | Sun Pharma Advanced Research Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioavailability Study of SPARC001 in Healthy Adult Volunteers (PHASE1)
- Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers (PHASE1)
- Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reference001 - Hydrocodone CI brief — competitive landscape report
- Reference001 - Hydrocodone updates RSS · CI watch RSS
- Sun Pharma Advanced Research Company Limited portfolio CI